Literature DB >> 9636213

Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.

I Sora1, C Wichems, N Takahashi, X F Li, Z Zeng, R Revay, K P Lesch, D L Murphy, G R Uhl.   

Abstract

Cocaine and methylphenidate block uptake by neuronal plasma membrane transporters for dopamine, serotonin, and norepinephrine. Cocaine also blocks voltage-gated sodium channels, a property not shared by methylphenidate. Several lines of evidence have suggested that cocaine blockade of the dopamine transporter (DAT), perhaps with additional contributions from serotonin transporter (5-HTT) recognition, was key to its rewarding actions. We now report that knockout mice without DAT and mice without 5-HTT establish cocaine-conditioned place preferences. Each strain displays cocaine-conditioned place preference in this major mouse model for assessing drug reward, while methylphenidate-conditioned place preference is also maintained in DAT knockout mice. These results have substantial implications for understanding cocaine actions and for strategies to produce anticocaine medications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636213      PMCID: PMC22727          DOI: 10.1073/pnas.95.13.7699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.

Authors:  D C Roberts; M E Corcoran; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-09-28       Impact factor: 5.182

3.  Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Reinforcing and subjective effects of several anorectics in normal human volunteers.

Authors:  L D Chait; E H Uhlenhuth; C E Johanson
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

5.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.

Authors:  B Giros; M Jaber; S R Jones; R M Wightman; M G Caron
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

6.  Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys.

Authors:  M S Kleven; W L Woolverton
Journal:  Drug Alcohol Depend       Date:  1993-01       Impact factor: 4.492

7.  Fluoxetine alters the effects of intravenous cocaine in humans.

Authors:  S L Walsh; K L Preston; J T Sullivan; R Fromme; G E Bigelow
Journal:  J Clin Psychopharmacol       Date:  1994-12       Impact factor: 3.153

8.  Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures.

Authors:  D M Donovan; D J Vandenbergh; M P Perry; G S Bird; R Ingersoll; E Nanthakumar; G R Uhl
Journal:  Brain Res Mol Brain Res       Date:  1995-06

9.  Dopamine transporter immunoreactivity in rat brain.

Authors:  C Freed; R Revay; R A Vaughan; E Kriek; S Grant; G R Uhl; M J Kuhar
Journal:  J Comp Neurol       Date:  1995-08-21       Impact factor: 3.215

10.  Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.

Authors:  R D Spealman; B K Madras; J Bergman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

View more
  132 in total

1.  Behavioral screening for cocaine sensitivity in mutagenized zebrafish.

Authors:  T Darland; J E Dowling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior.

Authors:  Xiangru Xu; Mohamed R Mughal; F Scott Hall; Maria T G Perona; Paul J Pistell; Justin D Lathia; Srinivasulu Chigurupati; Kevin G Becker; Bruce Ladenheim; Laura E Niklason; George R Uhl; Jean Lud Cadet; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

Review 3.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

Review 4.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

6.  Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice.

Authors:  Teodora-Adriana Perles-Barbacaru; Daniel Procissi; Andrey V Demyanenko; F Scott Hall; George R Uhl; Russell E Jacobs
Journal:  Neuroimage       Date:  2010-12-23       Impact factor: 6.556

7.  Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Authors:  Rong Chen; Michael R Tilley; Hua Wei; Fuwen Zhou; Fu-Ming Zhou; San Ching; Ning Quan; Robert L Stephens; Erik R Hill; Timothy Nottoli; Dawn D Han; Howard H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

8.  Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice.

Authors:  Morgane Thomsen; F Scott Hall; George R Uhl; S Barak Caine
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 9.  A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Authors:  Meredith A Fox; Anne M Andrews; Jens R Wendland; Klaus-Peter Lesch; Andrew Holmes; Dennis L Murphy
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

10.  Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Seth D Norrholm; Peter A Crooks
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.